Literature DB >> 6932529

Role of natural killer cells in the destruction of circulating tumor emboli.

N Hanna, I J Fidler.   

Abstract

A close correlation was demonstrated between levels of host natural cytotoxic (NC) and/or natural killer (NK) cell activity and capacity to eliminate blood-borne tumor cells. The outcome of experimental metastasis of several tumors with defined biologic behavior was studied in syngeneic mice exhibiting low NK cell activity [3-wk-old normal mice and cyclophosphamide (Cy)-treated adult mice] and high NK cell activity (normal adult mice). An iv injection of metastatic tumor cells into 3-week-old or Cy-treated mice markedly enhanced experimental pulmonary metastasis. The increased incidence of metastasis in mice exhibiting low activity of NK cells was not due to enhanced tumor cell arrest in the lung but rather to increased tumor cell survival. Boosting the NK activity of 3-week-old, but not Cy-treated, mice with interferon inducers inhibited metastasis formation. The adoptive transfer of spleen cells from syngeneic mice or allogeneic nude mice that have high NK activity shortly before (but not after) iv tumor challenge abrogated the Cy-induced enhancement of metastasis. The reactive lymphoid cells were non-T, nonadherent to nylon wool, sensitive to Cy treatment, and endowed with a natural ability to kill tumor cells during a short (12-24 hr) period. The conclusions were that NC-NK cells are important in host defense against circulating tumor cells and therefore can prevent the development of tumor cells into metastases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932529     DOI: 10.1093/jnci/65.4.801

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  99 in total

1.  No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma.

Authors:  Tadamichi Hirano; Junichi Yamanaka; Yuji Iimuro; Jiro Fujimoto
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.

Authors:  I Florentin; D Nolibe; J P Giroud
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

4.  Predominant role of alpha 4-integrins for distinct steps of lymphoma metastasis.

Authors:  U Gosslar; P Jonas; A Luz; A Lifka; D Naor; A Hamann; B Holzmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 5.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

6.  Non-cytotoxic asialo-GM1-positive cells exert antimetastatic activity.

Authors:  L Strzadala; I Rak; E Ziolo; M Paprocka; C Radzikowski; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.

Authors:  E Gorelik; R H Wiltrout; M J Brunda; W E Bere; R B Herberman
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

8.  Activation of rat alveolar macrophages and protection against i.v. injected tumor cells by intratracheal administration of trehalose dimycolate.

Authors:  D Nolibe; R Masse; J P Tenu; M Lepoivre; J F Petit
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Inhibition of experimental pulmonary metastasis in mice by beta-cyclodextrin-benzaldehyde.

Authors:  H Ochiai; S Niwayama; K Masuyama
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

10.  Natural killer cell activity in inflammatory joint disease.

Authors:  R D Armstrong; G S Panayi
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.